Rothschild Investment LLC Pulmonx Corp Transaction History
Rothschild Investment LLC
- $1.53 Trillion
- Q4 2024
A detailed history of Rothschild Investment LLC transactions in Pulmonx Corp stock. As of the latest transaction made, Rothschild Investment LLC holds 30 shares of LUNG stock, worth $209. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30Holding current value
$209% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LUNG
# of Institutions
130Shares Held
31.4MCall Options Held
500Put Options Held
213K-
Primecap Management CO Pasadena, CA5.51MShares$38.5 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.07MShares$21.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$18.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$16 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.53MShares$10.7 Million0.26% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $261M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...